These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka. Basnayake S; Higgins JE; Miller PC; Rogers SM; Kelly SE Stud Fam Plann; 1984; 15(6 Pt 1):285-90. PubMed ID: 6393460 [TBL] [Abstract][Full Text] [Related]
29. Four years overall experience with a new low estrogen -- low progestogen oral contraceptive. Brat T Acta Obstet Gynecol Scand Suppl; 1976; 54():67-70. PubMed ID: 788448 [TBL] [Abstract][Full Text] [Related]
30. [Longterm study of a minipill consisting of 30 mcg ethinyl estradiol and 1 mg norethisterone acetate]. Cohen J; Crouzette J Contracept Fertil Sex (Paris); 1976 Mar; 4(2):111-4. PubMed ID: 1261725 [No Abstract] [Full Text] [Related]
31. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201 [TBL] [Abstract][Full Text] [Related]
32. Three triphasic oral contraceptives now available in U.S. Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912 [TBL] [Abstract][Full Text] [Related]
33. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history]. Manuilova IA; Dubnitskaia LV; Korsakov SG Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038 [TBL] [Abstract][Full Text] [Related]
34. Optimum dosage of an oral contraceptive. A report from the study of seven combinations of norgestimate and ethinyl estradiol. Lawson JS; Yuliano SE; Pasquale SA; Osterman JJ Am J Obstet Gynecol; 1979 Jun; 134(3):315-20. PubMed ID: 377968 [TBL] [Abstract][Full Text] [Related]
35. Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol. Boyd RA; Zegarac EA; Posvar EL; Flack MR Contraception; 2001 Feb; 63(2):71-6. PubMed ID: 11292470 [TBL] [Abstract][Full Text] [Related]
36. [Clinical use of combined contraceptive preparations of Hungarian manufacture]. Farkas M Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870 [TBL] [Abstract][Full Text] [Related]
37. Analysis of a multicentre trial of a new low-dose oral contraceptive in Great Britain. Bye PG Acta Obstet Gynecol Scand Suppl; 1976; 54():61-6. PubMed ID: 788447 [TBL] [Abstract][Full Text] [Related]
38. Clinical results with a new low dose oral contraceptive utilizing norethindrone/ethinyl estradiol. Pasquale SA; Yuliano E Contraception; 1975 Nov; 12(5):495-503. PubMed ID: 1192736 [No Abstract] [Full Text] [Related]
39. Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators. Symons J; Kempfert N; Speroff L Obstet Gynecol; 2000 Sep; 96(3):366-72. PubMed ID: 10960627 [TBL] [Abstract][Full Text] [Related]
40. Alopecia related to low dose oral contraceptive. Yokoyama Y; Sato S; Saito Y Arch Gynecol Obstet; 2002 Jan; 266(1):46-7. PubMed ID: 11998965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]